Aptus Pharma IPO GMP, Grey Market Premium Today
Aptus Pharma IPO's GMP is ₹4 on September 30, 2025. If you add this to the IPO price, which is ₹70, you get an estimated listing price of ₹74. This means there's a potential gain of 5.7% per share.The GMP is updated daily, and recently it's been towards the lower side.Keep an eye on daily updates to see how the IPO price is trending.
Last Updated - 30 September, 2025 5:00 am
|
Check Live IPO GMP List 👈
|
| Listed |
Aptus Pharma IPO GMP Today is - ₹4
| IPO Price : | 70 Rs |
| IPO GMP : | 4 Rs 👈 |
| Expected Listing Price : | 70+4 = 74 Rs |
| Expected IPO Gain %: | 5.7% 👈 |
| Lot Shares: | 2000 |
| Lot Price: | 1,40,000 Rs |
| Lot Expected Profit: | 8,000 Rs |
Aptus Pharma IPO Expected Profit
| Number Of Lots | Lot Shares | Lot Price | Lot Profit | Lot Expected Listing |
|---|---|---|---|---|
| 1 | 2000 | 1,40,000 Rs | 8,000 Rs | 1,48,000 Rs |
| 2 | 4000 | 2,80,000 Rs | 16,000 Rs | 2,96,000 Rs |
| 3 | 6000 | 4,20,000 Rs | 24,000 Rs | 4,44,000 Rs |
| 4 | 8000 | 5,60,000 Rs | 32,000 Rs | 5,92,000 Rs |
| 5 | 10000 | 7,00,000 Rs | 40,000 Rs | 7,40,000 Rs |
| 6 | 12000 | 8,40,000 Rs | 48,000 Rs | 8,88,000 Rs |
| 7 | 14000 | 9,80,000 Rs | 56,000 Rs | 10,36,000 Rs |
| 8 | 16000 | 11,20,000 Rs | 64,000 Rs | 11,84,000 Rs |
| 9 | 18000 | 12,60,000 Rs | 72,000 Rs | 13,32,000 Rs |
| 10 | 20000 | 14,00,000 Rs | 80,000 Rs | 14,80,000 Rs |
| 11 | 22000 | 15,40,000 Rs | 88,000 Rs | 16,28,000 Rs |
| 12 | 24000 | 16,80,000 Rs | 96,000 Rs | 17,76,000 Rs |
| 13 | 26000 | 18,20,000 Rs | 1,04,000 Rs | 19,24,000 Rs |
Aptus Pharma IPO Dates
| IPO Activity | Date |
|---|---|
| Open Date: | 23 September, 2025 |
| Close Date: | 25 September, 2025 |
| Allotment Date: | 26 September, 2025 |
| Refund Date: | 29 September, 2025 |
| Shares Credit Date: | 29 September, 2025 |
| Listing Date: | 30 September, 2025 |
Aptus Pharma IPO GMP Grey Market Premium FAQs
Q.What is Aptus Pharma IPO GMP Today?
Ans.Aptus Pharma IPO GMP is ₹4 as of today.
Q.What is Aptus Pharma IPO Expected Returns?
Ans.Aptus Pharma IPO Expected Returns is 5.7%.